ZOFENOPRIL MYLAN 30mg tablets medication leaflet

C09AA15 zofenopril • Cardiovascular system | Ace inhibitors, plain

Zofenopril is a medication from the class of angiotensin-converting enzyme (ACE) inhibitors, used to treat high blood pressure and heart failure. It helps lower blood pressure by relaxing blood vessels, thereby reducing the workload on the heart and improving blood circulation.

Zofenopril is also used to protect the heart after an acute myocardial infarction, especially in patients with left ventricular dysfunction. By reducing the activity of angiotensin II, a hormone that causes blood vessel constriction, zofenopril helps prevent further damage to the heart and blood vessels.

Side effects may include dizziness, dry cough, fatigue, or, in rare cases, allergic reactions. It is important to use zofenopril as directed by a healthcare provider, and patients should avoid concurrent use with potassium supplements or potassium-sparing diuretics to prevent hyperkalemia.

General data about ZOFENOPRIL MYLAN 30mg

Substance: zofenopril

Date of last drug list: 01-01-2021

Commercial code: W67155008

Concentration: 30mg

Pharmaceutical form: tablets

Quantity: 500

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: MC DERMOTT LABORATORIES LIMITED T/A - IRLANDA

Holder: MYLAN IRELAND LIMITED - IRLANDA

Number: 9325/2016/08

Shelf life: 3 years; after the first opening of the bottle- 30 days

Concentrations available for zofenopril

30mg, 7.5mg

Combinations with other substances